Global Viral Vector-Based Gene Therapy Drugs Supply, Demand and Key Producers, 2024-2030

Description

Viral vector-based gene therapy drugs are pharmaceutical products that use viral vectors to deliver therapeutic genes into target cells for the treatment of genetic disorders or diseases. These drugs typically contain modified viruses as vectors to efficiently and safely transfer genetic material into the cells of patients, aiming to correct genetic mutations or induce specific therapeutic effects.

The global Viral Vector-Based Gene Therapy Drugs market size is expected to reach $ million by 2030, rising at a market growth of %CAGR during the forecast period (2024-2030).

This report studies the global Viral Vector-Based Gene Therapy Drugs demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Viral Vector-Based Gene Therapy Drugs, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Viral Vector-Based Gene Therapy Drugs that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Viral Vector-Based Gene Therapy Drugs total market, 2019-2030, (USD Million)
Global Viral Vector-Based Gene Therapy Drugs total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Viral Vector-Based Gene Therapy Drugs total market, key domestic companies, and share, (USD Million)
Global Viral Vector-Based Gene Therapy Drugs revenue by player, revenue and market share 2019-2024, (USD Million)
Global Viral Vector-Based Gene Therapy Drugs total market by Type, CAGR, 2019-2030, (USD Million)
Global Viral Vector-Based Gene Therapy Drugs total market by Application, CAGR, 2019-2030, (USD Million)
This report profiles major players in the global Viral Vector-Based Gene Therapy Drugs market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GSK, MolMed, GILD, JW Therapeutics, Sibiono, Latima, Novartis, Bluebird Bio, Thermo Fisher Scientific, Intas, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Viral Vector-Based Gene Therapy Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Viral Vector-Based Gene Therapy Drugs Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Viral Vector-Based Gene Therapy Drugs Market, Segmentation by Type
    Retroviral Vector
    Adenovirus Vector
    Lentiviral Vector
    Others

Global Viral Vector-Based Gene Therapy Drugs Market, Segmentation by Application:
    Hospital
    Diagnostic and Testing Laboratories
    Academic and Research Organizations
    Others

Companies Profiled:
    GSK
    MolMed
    GILD
    JW Therapeutics
    Sibiono
    Latima
    Novartis
    Bluebird Bio
    Thermo Fisher Scientific
    Intas
    BMS
    Orchard Therapeutics
    Shanghai Sunway Biotech
    uniQure
    Spark Therapeutics

Key Questions Answered
1. How big is the global Viral Vector-Based Gene Therapy Drugs market?
2. What is the demand of the global Viral Vector-Based Gene Therapy Drugs market?
3. What is the year over year growth of the global Viral Vector-Based Gene Therapy Drugs market?
4. What is the total value of the global Viral Vector-Based Gene Therapy Drugs market?
5. Who are the Major Players in the global Viral Vector-Based Gene Therapy Drugs market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Viral Vector-Based Gene Therapy Drugs Introduction
    1.2 World Viral Vector-Based Gene Therapy Drugs Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World Viral Vector-Based Gene Therapy Drugs Total Market by Region (by Headquarter Location)
        1.3.1 World Viral Vector-Based Gene Therapy Drugs Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Based Company Viral Vector-Based Gene Therapy Drugs Revenue (2019-2030)
        1.3.3 China Based Company Viral Vector-Based Gene Therapy Drugs Revenue (2019-2030)
        1.3.4 Europe Based Company Viral Vector-Based Gene Therapy Drugs Revenue (2019-2030)
        1.3.5 Japan Based Company Viral Vector-Based Gene Therapy Drugs Revenue (2019-2030)
        1.3.6 South Korea Based Company Viral Vector-Based Gene Therapy Drugs Revenue (2019-2030)
        1.3.7 ASEAN Based Company Viral Vector-Based Gene Therapy Drugs Revenue (2019-2030)
        1.3.8 India Based Company Viral Vector-Based Gene Therapy Drugs Revenue (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Viral Vector-Based Gene Therapy Drugs Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Major Market Trends

2 Demand Summary
    2.1 World Viral Vector-Based Gene Therapy Drugs Consumption Value (2019-2030)
    2.2 World Viral Vector-Based Gene Therapy Drugs Consumption Value by Region
        2.2.1 World Viral Vector-Based Gene Therapy Drugs Consumption Value by Region (2019-2024)
        2.2.2 World Viral Vector-Based Gene Therapy Drugs Consumption Value Forecast by Region (2025-2030)
    2.3 United States Viral Vector-Based Gene Therapy Drugs Consumption Value (2019-2030)
    2.4 China Viral Vector-Based Gene Therapy Drugs Consumption Value (2019-2030)
    2.5 Europe Viral Vector-Based Gene Therapy Drugs Consumption Value (2019-2030)
    2.6 Japan Viral Vector-Based Gene Therapy Drugs Consumption Value (2019-2030)
    2.7 South Korea Viral Vector-Based Gene Therapy Drugs Consumption Value (2019-2030)
    2.8 ASEAN Viral Vector-Based Gene Therapy Drugs Consumption Value (2019-2030)
    2.9 India Viral Vector-Based Gene Therapy Drugs Consumption Value (2019-2030)

3 World Viral Vector-Based Gene Therapy Drugs Companies Competitive Analysis
    3.1 World Viral Vector-Based Gene Therapy Drugs Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Viral Vector-Based Gene Therapy Drugs Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Viral Vector-Based Gene Therapy Drugs in 2023
        3.2.3 Global Concentration Ratios (CR8) for Viral Vector-Based Gene Therapy Drugs in 2023
    3.3 Viral Vector-Based Gene Therapy Drugs Company Evaluation Quadrant
    3.4 Viral Vector-Based Gene Therapy Drugs Market: Overall Company Footprint Analysis
        3.4.1 Viral Vector-Based Gene Therapy Drugs Market: Region Footprint
        3.4.2 Viral Vector-Based Gene Therapy Drugs Market: Company Product Type Footprint
        3.4.3 Viral Vector-Based Gene Therapy Drugs Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers & Acquisitions Activity

4 United States VS China VS Rest of World (by Headquarter Location)
    4.1 United States VS China: Viral Vector-Based Gene Therapy Drugs Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Viral Vector-Based Gene Therapy Drugs Revenue Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: Viral Vector-Based Gene Therapy Drugs Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: Viral Vector-Based Gene Therapy Drugs Consumption Value Comparison
        4.2.1 United States VS China: Viral Vector-Based Gene Therapy Drugs Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Viral Vector-Based Gene Therapy Drugs Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based Viral Vector-Based Gene Therapy Drugs Companies and Market Share, 2019-2024
        4.3.1 United States Based Viral Vector-Based Gene Therapy Drugs Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Viral Vector-Based Gene Therapy Drugs Revenue, (2019-2024)
    4.4 China Based Companies Viral Vector-Based Gene Therapy Drugs Revenue and Market Share, 2019-2024
        4.4.1 China Based Viral Vector-Based Gene Therapy Drugs Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Viral Vector-Based Gene Therapy Drugs Revenue, (2019-2024)
    4.5 Rest of World Based Viral Vector-Based Gene Therapy Drugs Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based Viral Vector-Based Gene Therapy Drugs Companies, Headquarters (Province, Country)
        4.5.2 Rest of World Based Companies Viral Vector-Based Gene Therapy Drugs Revenue (2019-2024)

5 Market Analysis by Type
    5.1 World Viral Vector-Based Gene Therapy Drugs Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Retroviral Vector
        5.2.2 Adenovirus Vector
        5.2.3 Lentiviral Vector
        5.2.4 Others
    5.3 Market Segment by Type
        5.3.1 World Viral Vector-Based Gene Therapy Drugs Market Size by Type (2019-2024)
        5.3.2 World Viral Vector-Based Gene Therapy Drugs Market Size by Type (2025-2030)
        5.3.3 World Viral Vector-Based Gene Therapy Drugs Market Size Market Share by Type (2025-2030)

6 Market Analysis by Application
    6.1 World Viral Vector-Based Gene Therapy Drugs Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Hospital
        6.2.2 Diagnostic and Testing Laboratories
        6.2.3 Academic and Research Organizations
        6.2.4 Others
    6.3 Market Segment by Application
        6.3.1 World Viral Vector-Based Gene Therapy Drugs Market Size by Application (2019-2024)
        6.3.2 World Viral Vector-Based Gene Therapy Drugs Market Size by Application (2025-2030)
        6.3.3 World Viral Vector-Based Gene Therapy Drugs Market Size Market Share by Application (2019-2030)

7 Company Profiles
    7.1 GSK
        7.1.1 GSK Details
        7.1.2 GSK Major Business
        7.1.3 GSK Viral Vector-Based Gene Therapy Drugs Product and Services
        7.1.4 GSK Viral Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 GSK Recent Developments/Updates
        7.1.6 GSK Competitive Strengths & Weaknesses
    7.2 MolMed
        7.2.1 MolMed Details
        7.2.2 MolMed Major Business
        7.2.3 MolMed Viral Vector-Based Gene Therapy Drugs Product and Services
        7.2.4 MolMed Viral Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 MolMed Recent Developments/Updates
        7.2.6 MolMed Competitive Strengths & Weaknesses
    7.3 GILD
        7.3.1 GILD Details
        7.3.2 GILD Major Business
        7.3.3 GILD Viral Vector-Based Gene Therapy Drugs Product and Services
        7.3.4 GILD Viral Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 GILD Recent Developments/Updates
        7.3.6 GILD Competitive Strengths & Weaknesses
    7.4 JW Therapeutics
        7.4.1 JW Therapeutics Details
        7.4.2 JW Therapeutics Major Business
        7.4.3 JW Therapeutics Viral Vector-Based Gene Therapy Drugs Product and Services
        7.4.4 JW Therapeutics Viral Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 JW Therapeutics Recent Developments/Updates
        7.4.6 JW Therapeutics Competitive Strengths & Weaknesses
    7.5 Sibiono
        7.5.1 Sibiono Details
        7.5.2 Sibiono Major Business
        7.5.3 Sibiono Viral Vector-Based Gene Therapy Drugs Product and Services
        7.5.4 Sibiono Viral Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 Sibiono Recent Developments/Updates
        7.5.6 Sibiono Competitive Strengths & Weaknesses
    7.6 Latima
        7.6.1 Latima Details
        7.6.2 Latima Major Business
        7.6.3 Latima Viral Vector-Based Gene Therapy Drugs Product and Services
        7.6.4 Latima Viral Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 Latima Recent Developments/Updates
        7.6.6 Latima Competitive Strengths & Weaknesses
    7.7 Novartis
        7.7.1 Novartis Details
        7.7.2 Novartis Major Business
        7.7.3 Novartis Viral Vector-Based Gene Therapy Drugs Product and Services
        7.7.4 Novartis Viral Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 Novartis Recent Developments/Updates
        7.7.6 Novartis Competitive Strengths & Weaknesses
    7.8 Bluebird Bio
        7.8.1 Bluebird Bio Details
        7.8.2 Bluebird Bio Major Business
        7.8.3 Bluebird Bio Viral Vector-Based Gene Therapy Drugs Product and Services
        7.8.4 Bluebird Bio Viral Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.8.5 Bluebird Bio Recent Developments/Updates
        7.8.6 Bluebird Bio Competitive Strengths & Weaknesses
    7.9 Thermo Fisher Scientific
        7.9.1 Thermo Fisher Scientific Details
        7.9.2 Thermo Fisher Scientific Major Business
        7.9.3 Thermo Fisher Scientific Viral Vector-Based Gene Therapy Drugs Product and Services
        7.9.4 Thermo Fisher Scientific Viral Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.9.5 Thermo Fisher Scientific Recent Developments/Updates
        7.9.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
    7.10 Intas
        7.10.1 Intas Details
        7.10.2 Intas Major Business
        7.10.3 Intas Viral Vector-Based Gene Therapy Drugs Product and Services
        7.10.4 Intas Viral Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.10.5 Intas Recent Developments/Updates
        7.10.6 Intas Competitive Strengths & Weaknesses
    7.11 BMS
        7.11.1 BMS Details
        7.11.2 BMS Major Business
        7.11.3 BMS Viral Vector-Based Gene Therapy Drugs Product and Services
        7.11.4 BMS Viral Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.11.5 BMS Recent Developments/Updates
        7.11.6 BMS Competitive Strengths & Weaknesses
    7.12 Orchard Therapeutics
        7.12.1 Orchard Therapeutics Details
        7.12.2 Orchard Therapeutics Major Business
        7.12.3 Orchard Therapeutics Viral Vector-Based Gene Therapy Drugs Product and Services
        7.12.4 Orchard Therapeutics Viral Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.12.5 Orchard Therapeutics Recent Developments/Updates
        7.12.6 Orchard Therapeutics Competitive Strengths & Weaknesses
    7.13 Shanghai Sunway Biotech
        7.13.1 Shanghai Sunway Biotech Details
        7.13.2 Shanghai Sunway Biotech Major Business
        7.13.3 Shanghai Sunway Biotech Viral Vector-Based Gene Therapy Drugs Product and Services
        7.13.4 Shanghai Sunway Biotech Viral Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.13.5 Shanghai Sunway Biotech Recent Developments/Updates
        7.13.6 Shanghai Sunway Biotech Competitive Strengths & Weaknesses
    7.14 uniQure
        7.14.1 uniQure Details
        7.14.2 uniQure Major Business
        7.14.3 uniQure Viral Vector-Based Gene Therapy Drugs Product and Services
        7.14.4 uniQure Viral Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.14.5 uniQure Recent Developments/Updates
        7.14.6 uniQure Competitive Strengths & Weaknesses
    7.15 Spark Therapeutics
        7.15.1 Spark Therapeutics Details
        7.15.2 Spark Therapeutics Major Business
        7.15.3 Spark Therapeutics Viral Vector-Based Gene Therapy Drugs Product and Services
        7.15.4 Spark Therapeutics Viral Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024)
        7.15.5 Spark Therapeutics Recent Developments/Updates
        7.15.6 Spark Therapeutics Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Viral Vector-Based Gene Therapy Drugs Industry Chain
    8.2 Viral Vector-Based Gene Therapy Drugs Upstream Analysis
    8.3 Viral Vector-Based Gene Therapy Drugs Midstream Analysis
    8.4 Viral Vector-Based Gene Therapy Drugs Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. World Viral Vector-Based Gene Therapy Drugs Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
 Table 2. World Viral Vector-Based Gene Therapy Drugs Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
 Table 3. World Viral Vector-Based Gene Therapy Drugs Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
 Table 4. World Viral Vector-Based Gene Therapy Drugs Revenue Market Share by Region (2019-2024), (by Headquarter Location)
 Table 5. World Viral Vector-Based Gene Therapy Drugs Revenue Market Share by Region (2025-2030), (by Headquarter Location)
 Table 6. Major Market Trends
 Table 7. World Viral Vector-Based Gene Therapy Drugs Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
 Table 8. World Viral Vector-Based Gene Therapy Drugs Consumption Value by Region (2019-2024) & (USD Million)
 Table 9. World Viral Vector-Based Gene Therapy Drugs Consumption Value Forecast by Region (2025-2030) & (USD Million)
 Table 10. World Viral Vector-Based Gene Therapy Drugs Revenue by Player (2019-2024) & (USD Million)
 Table 11. Revenue Market Share of Key Viral Vector-Based Gene Therapy Drugs Players in 2023
 Table 12. World Viral Vector-Based Gene Therapy Drugs Industry Rank of Major Player, Based on Revenue in 2023
 Table 13. Global Viral Vector-Based Gene Therapy Drugs Company Evaluation Quadrant
 Table 14. Head Office of Key Viral Vector-Based Gene Therapy Drugs Players
 Table 15. Viral Vector-Based Gene Therapy Drugs Market: Company Product Type Footprint
 Table 16. Viral Vector-Based Gene Therapy Drugs Market: Company Product Application Footprint
 Table 17. Viral Vector-Based Gene Therapy Drugs Mergers & Acquisitions Activity
 Table 18. United States VS China Viral Vector-Based Gene Therapy Drugs Revenue Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 19. United States VS China Viral Vector-Based Gene Therapy Drugs Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 20. United States Based Viral Vector-Based Gene Therapy Drugs Companies, Headquarters (States, Country)
 Table 21. United States Based Companies Viral Vector-Based Gene Therapy Drugs Revenue, (2019-2024) & (USD Million)
 Table 22. United States Based Companies Viral Vector-Based Gene Therapy Drugs Revenue Market Share (2019-2024)
 Table 23. China Based Viral Vector-Based Gene Therapy Drugs Companies, Headquarters (Province, Country)
 Table 24. China Based Companies Viral Vector-Based Gene Therapy Drugs Revenue, (2019-2024) & (USD Million)
 Table 25. China Based Companies Viral Vector-Based Gene Therapy Drugs Revenue Market Share (2019-2024)
 Table 26. Rest of World Based Viral Vector-Based Gene Therapy Drugs Companies, Headquarters (Province, Country)
 Table 27. Rest of World Based Companies Viral Vector-Based Gene Therapy Drugs Revenue (2019-2024) & (USD Million)
 Table 28. Rest of World Based Companies Viral Vector-Based Gene Therapy Drugs Revenue Market Share (2019-2024)
 Table 29. World Viral Vector-Based Gene Therapy Drugs Market Size by Type, (USD Million), 2019 & 2023 & 2030
 Table 30. World Viral Vector-Based Gene Therapy Drugs Market Size Value by Type (2019-2024) & (USD Million)
 Table 31. World Viral Vector-Based Gene Therapy Drugs Market Size by Type (2025-2030) & (USD Million)
 Table 32. World Viral Vector-Based Gene Therapy Drugs Market Size by Application, (USD Million), 2019 & 2023 & 2030
 Table 33. World Viral Vector-Based Gene Therapy Drugs Market Size by Application (2019-2024) & (USD Million)
 Table 34. World Viral Vector-Based Gene Therapy Drugs Market Size by Application (2025-2030) & (USD Million)
 Table 35. GSK Basic Information, Manufacturing Base and Competitors
 Table 36. GSK Major Business
 Table 37. GSK Viral Vector-Based Gene Therapy Drugs Product and Services
 Table 38. GSK Viral Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 39. GSK Recent Developments/Updates
 Table 40. GSK Competitive Strengths & Weaknesses
 Table 41. MolMed Basic Information, Manufacturing Base and Competitors
 Table 42. MolMed Major Business
 Table 43. MolMed Viral Vector-Based Gene Therapy Drugs Product and Services
 Table 44. MolMed Viral Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 45. MolMed Recent Developments/Updates
 Table 46. MolMed Competitive Strengths & Weaknesses
 Table 47. GILD Basic Information, Manufacturing Base and Competitors
 Table 48. GILD Major Business
 Table 49. GILD Viral Vector-Based Gene Therapy Drugs Product and Services
 Table 50. GILD Viral Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 51. GILD Recent Developments/Updates
 Table 52. GILD Competitive Strengths & Weaknesses
 Table 53. JW Therapeutics Basic Information, Manufacturing Base and Competitors
 Table 54. JW Therapeutics Major Business
 Table 55. JW Therapeutics Viral Vector-Based Gene Therapy Drugs Product and Services
 Table 56. JW Therapeutics Viral Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 57. JW Therapeutics Recent Developments/Updates
 Table 58. JW Therapeutics Competitive Strengths & Weaknesses
 Table 59. Sibiono Basic Information, Manufacturing Base and Competitors
 Table 60. Sibiono Major Business
 Table 61. Sibiono Viral Vector-Based Gene Therapy Drugs Product and Services
 Table 62. Sibiono Viral Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 63. Sibiono Recent Developments/Updates
 Table 64. Sibiono Competitive Strengths & Weaknesses
 Table 65. Latima Basic Information, Manufacturing Base and Competitors
 Table 66. Latima Major Business
 Table 67. Latima Viral Vector-Based Gene Therapy Drugs Product and Services
 Table 68. Latima Viral Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 69. Latima Recent Developments/Updates
 Table 70. Latima Competitive Strengths & Weaknesses
 Table 71. Novartis Basic Information, Manufacturing Base and Competitors
 Table 72. Novartis Major Business
 Table 73. Novartis Viral Vector-Based Gene Therapy Drugs Product and Services
 Table 74. Novartis Viral Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 75. Novartis Recent Developments/Updates
 Table 76. Novartis Competitive Strengths & Weaknesses
 Table 77. Bluebird Bio Basic Information, Manufacturing Base and Competitors
 Table 78. Bluebird Bio Major Business
 Table 79. Bluebird Bio Viral Vector-Based Gene Therapy Drugs Product and Services
 Table 80. Bluebird Bio Viral Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 81. Bluebird Bio Recent Developments/Updates
 Table 82. Bluebird Bio Competitive Strengths & Weaknesses
 Table 83. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
 Table 84. Thermo Fisher Scientific Major Business
 Table 85. Thermo Fisher Scientific Viral Vector-Based Gene Therapy Drugs Product and Services
 Table 86. Thermo Fisher Scientific Viral Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 87. Thermo Fisher Scientific Recent Developments/Updates
 Table 88. Thermo Fisher Scientific Competitive Strengths & Weaknesses
 Table 89. Intas Basic Information, Manufacturing Base and Competitors
 Table 90. Intas Major Business
 Table 91. Intas Viral Vector-Based Gene Therapy Drugs Product and Services
 Table 92. Intas Viral Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 93. Intas Recent Developments/Updates
 Table 94. Intas Competitive Strengths & Weaknesses
 Table 95. BMS Basic Information, Manufacturing Base and Competitors
 Table 96. BMS Major Business
 Table 97. BMS Viral Vector-Based Gene Therapy Drugs Product and Services
 Table 98. BMS Viral Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 99. BMS Recent Developments/Updates
 Table 100. BMS Competitive Strengths & Weaknesses
 Table 101. Orchard Therapeutics Basic Information, Manufacturing Base and Competitors
 Table 102. Orchard Therapeutics Major Business
 Table 103. Orchard Therapeutics Viral Vector-Based Gene Therapy Drugs Product and Services
 Table 104. Orchard Therapeutics Viral Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 105. Orchard Therapeutics Recent Developments/Updates
 Table 106. Orchard Therapeutics Competitive Strengths & Weaknesses
 Table 107. Shanghai Sunway Biotech Basic Information, Manufacturing Base and Competitors
 Table 108. Shanghai Sunway Biotech Major Business
 Table 109. Shanghai Sunway Biotech Viral Vector-Based Gene Therapy Drugs Product and Services
 Table 110. Shanghai Sunway Biotech Viral Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 111. Shanghai Sunway Biotech Recent Developments/Updates
 Table 112. Shanghai Sunway Biotech Competitive Strengths & Weaknesses
 Table 113. uniQure Basic Information, Manufacturing Base and Competitors
 Table 114. uniQure Major Business
 Table 115. uniQure Viral Vector-Based Gene Therapy Drugs Product and Services
 Table 116. uniQure Viral Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 117. uniQure Recent Developments/Updates
 Table 118. uniQure Competitive Strengths & Weaknesses
 Table 119. Spark Therapeutics Basic Information, Manufacturing Base and Competitors
 Table 120. Spark Therapeutics Major Business
 Table 121. Spark Therapeutics Viral Vector-Based Gene Therapy Drugs Product and Services
 Table 122. Spark Therapeutics Viral Vector-Based Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 123. Spark Therapeutics Recent Developments/Updates
 Table 124. Spark Therapeutics Competitive Strengths & Weaknesses
 Table 125. Global Key Players of Viral Vector-Based Gene Therapy Drugs Upstream (Raw Materials)
 Table 126. Global Viral Vector-Based Gene Therapy Drugs Typical Customers


List of Figures
 Figure 1. Viral Vector-Based Gene Therapy Drugs Picture
 Figure 2. World Viral Vector-Based Gene Therapy Drugs Total Revenue: 2019 & 2023 & 2030, (USD Million)
 Figure 3. World Viral Vector-Based Gene Therapy Drugs Total Revenue (2019-2030) & (USD Million)
 Figure 4. World Viral Vector-Based Gene Therapy Drugs Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
 Figure 5. World Viral Vector-Based Gene Therapy Drugs Revenue Market Share by Region (2019-2030), (by Headquarter Location)
 Figure 6. United States Based Company Viral Vector-Based Gene Therapy Drugs Revenue (2019-2030) & (USD Million)
 Figure 7. China Based Company Viral Vector-Based Gene Therapy Drugs Revenue (2019-2030) & (USD Million)
 Figure 8. Europe Based Company Viral Vector-Based Gene Therapy Drugs Revenue (2019-2030) & (USD Million)
 Figure 9. Japan Based Company Viral Vector-Based Gene Therapy Drugs Revenue (2019-2030) & (USD Million)
 Figure 10. South Korea Based Company Viral Vector-Based Gene Therapy Drugs Revenue (2019-2030) & (USD Million)
 Figure 11. ASEAN Based Company Viral Vector-Based Gene Therapy Drugs Revenue (2019-2030) & (USD Million)
 Figure 12. India Based Company Viral Vector-Based Gene Therapy Drugs Revenue (2019-2030) & (USD Million)
 Figure 13. Viral Vector-Based Gene Therapy Drugs Market Drivers
 Figure 14. Factors Affecting Demand
 Figure 15. World Viral Vector-Based Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 16. World Viral Vector-Based Gene Therapy Drugs Consumption Value Market Share by Region (2019-2030)
 Figure 17. United States Viral Vector-Based Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 18. China Viral Vector-Based Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 19. Europe Viral Vector-Based Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 20. Japan Viral Vector-Based Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 21. South Korea Viral Vector-Based Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 22. ASEAN Viral Vector-Based Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 23. India Viral Vector-Based Gene Therapy Drugs Consumption Value (2019-2030) & (USD Million)
 Figure 24. Producer Shipments of Viral Vector-Based Gene Therapy Drugs by Player Revenue ($MM) and Market Share (%): 2023
 Figure 25. Global Four-firm Concentration Ratios (CR4) for Viral Vector-Based Gene Therapy Drugs Markets in 2023
 Figure 26. Global Four-firm Concentration Ratios (CR8) for Viral Vector-Based Gene Therapy Drugs Markets in 2023
 Figure 27. United States VS China: Viral Vector-Based Gene Therapy Drugs Revenue Market Share Comparison (2019 & 2023 & 2030)
 Figure 28. United States VS China: Viral Vector-Based Gene Therapy Drugs Consumption Value Market Share Comparison (2019 & 2023 & 2030)
 Figure 29. World Viral Vector-Based Gene Therapy Drugs Market Size by Type, (USD Million), 2019 & 2023 & 2030
 Figure 30. World Viral Vector-Based Gene Therapy Drugs Market Size Market Share by Type in 2023
 Figure 31. Retroviral Vector
 Figure 32. Adenovirus Vector
 Figure 33. Lentiviral Vector
 Figure 34. Others
 Figure 35. World Viral Vector-Based Gene Therapy Drugs Market Size Market Share by Type (2019-2030)
 Figure 36. World Viral Vector-Based Gene Therapy Drugs Market Size by Application, (USD Million), 2019 & 2023 & 2030
 Figure 37. World Viral Vector-Based Gene Therapy Drugs Market Size Market Share by Application in 2023
 Figure 38. Hospital
 Figure 39. Diagnostic and Testing Laboratories
 Figure 40. Academic and Research Organizations
 Figure 41. Others
 Figure 42. World Viral Vector-Based Gene Therapy Drugs Market Size Market Share by Application (2019-2030)
 Figure 43. Viral Vector-Based Gene Therapy Drugs Industrial Chain
 Figure 44. Methodology
 Figure 45. Research Process and Data Source

Companies Mentioned

GSK
MolMed
GILD
JW Therapeutics
Sibiono
Latima
Novartis
Bluebird Bio
Thermo Fisher Scientific
Intas
BMS
Orchard Therapeutics
Shanghai Sunway Biotech
uniQure
Spark Therapeutics